PROCEPT BioRobotics Corporation (PRCT)

61.09 +1.36 (+2.28%) 收市：04:00PM EDT

PROCEPT BioRobotics Corporation

150 Baytech Drive
San Jose, CA 95134
United States
650 232 7200
https://www.procept-biorobotics.com

版塊: Healthcare
行業: Medical Devices
全職員工: 626

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Reza Zadno Ph.D.	President, CEO & Director	1.13M	1.17M	1955
Mr. Kevin Waters	Executive VP & CFO	680.11k	3.1M	1977
Ms. Alaleh Nouri	EVP, Chief Legal Officer & Corporate Secretary	605.84k	1.63M	1979
Mr. Hisham Shiblaq	Executive VP & Chief Commercial Officer	645.95k	無	1976
Mr. Mohan F. Sancheti	Senior Vice President of Operations	無	無	1964
Mr. Barry Templin	Executive VP of Technology & Clinical Development	無	無	無
Mr. Matthew James Bacso C.F.A.	Vice President of Investor Relations	無	無	無
Ms. Stacey L. Porter	Chief People Officer	無	無	1976
Mr. Bijesh Chandran	Senior Vice President of Regulatory Affairs & Quality Assurance	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

公司管治

截至 2024年6月1日 止，PROCEPT BioRobotics Corporation 的 ISS 管治質素評分為 6。 Pillar 分數正在審核中：2；董事會：4；股東權利：8；現金賠償：9。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。